pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social
pubmed.ncbi.nlm.nih.gov/40389356/
✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed.
➡️ Risk stratification and screening needed!
@fudimmarat.bsky.social